Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-26
DOI
10.3389/fonc.2019.00963
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
- (2019) Giovanni Gravina et al. Cancers
- Blocking VEGF by Bevacizumab Compromises Electrophysiological and Morphological Properties of Hippocampal Neurons
- (2019) Pauline Latzer et al. Frontiers in Cellular Neuroscience
- Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
- (2019) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature
- (2019) Salvatore Grisanti et al. Journal of Neurosurgical Sciences
- Co-targeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma.
- (2018) Maleeha A Qazi et al. CANCER RESEARCH
- Crizotinib and erlotinib inhibits growth of c-Met + /EGFRvIII + primary human glioblastoma xenografts
- (2018) C. Rory Goodwin et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies
- (2018) Zhenyi An et al. ONCOGENE
- Prognostic significance of epidermal growth factor receptor expression in glioma patients
- (2018) Junhong Li et al. OncoTargets and Therapy
- Tumour treating fields in a combinational therapeutic approach
- (2018) Joshua Branter et al. Oncotarget
- EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma
- (2018) Carolin Offenhäuser et al. Cancers
- Overcoming therapeutic resistance in glioblastoma: the way forward
- (2017) Satoru Osuka et al. JOURNAL OF CLINICAL INVESTIGATION
- European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
- (2017) Michael Weller et al. LANCET ONCOLOGY
- Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
- (2017) Hua-fu Zhao et al. Molecular Cancer
- Antibody–drug conjugates in glioblastoma therapy: the right drugs to the right cells
- (2017) Hui K. Gan et al. Nature Reviews Clinical Oncology
- PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3
- (2017) Jorge A. Benitez et al. Nature Communications
- Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study
- (2017) Ping Zhu et al. Oncotarget
- Bevacizumab combined with chemotherapy for glioblastoma: a meta-analysis of randomized controlled trials
- (2017) Shou-Bo Yang et al. Oncotarget
- PDGF Family Expression in Glioblastoma Multiforme: Data Compilation from Ivy Glioblastoma Atlas Project Database
- (2017) Isabella Gomes Cantanhede et al. Scientific Reports
- Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
- (2017) Nichola Cruickshanks et al. Cancers
- EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines
- (2017) Debyani Chakravarty et al. Scientific Reports
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
- (2016) Jayashree Kalpathy-Cramer et al. JOURNAL OF NEURO-ONCOLOGY
- Simultaneous targeting of Eph receptors in glioblastoma
- (2016) Sara Ferluga et al. Oncotarget
- Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma
- (2016) Carl Koschmann et al. Oncotarget
- Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
- (2016) Yang Yi et al. Frontiers in Pharmacology
- Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling
- (2016) Antonina Frolov et al. Scientific Reports
- Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein
- (2015) Anna C. Navis et al. ACTA NEUROPATHOLOGICA
- Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas
- (2015) M. Verreault et al. CLINICAL CANCER RESEARCH
- Nonsurgical treatment of recurrent glioblastoma
- (2015) O. Gallego Current Oncology
- High levels of c-Met is associated with poor prognosis in glioblastoma
- (2015) Stine Asferg Petterson et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II study of PX-866 in recurrent glioblastoma
- (2015) M. W. Pitz et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
- (2015) Quinn T. Ostrom et al. NEURO-ONCOLOGY
- Downregulation of VEGF expression attenuates malignant biological behavior of C6 glioma stem cells
- (2014) QINGQUAN LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma
- (2014) Chengyuan Ma et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- MGMT Promoter Methylation Correlates with an Overall Survival Benefit in Chinese High-Grade Glioblastoma Patients Treated with Radiotherapy and Alkylating Agent-Based Chemotherapy: A Single-Institution Study
- (2014) Dong Shen et al. PLoS One
- In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like Cells
- (2014) Prakash Rath et al. Translational Oncology
- EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
- (2013) Bryan W. Day et al. CANCER CELL
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma
- (2013) J. J. Parker et al. NEURO-ONCOLOGY
- Angiogenesis in Glioblastoma
- (2013) Sunit Das et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of p53, epidermal growth factor receptor, Ki-67 and O6-methylguanine-DNA methyltransferase in human gliomas
- (2013) XINHUA HU et al. Oncology Letters
- An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
- (2012) Fadila Guessous et al. Anti-Cancer Agents in Medicinal Chemistry
- Biology, genetics and imaging of glial cell tumours
- (2012) C Walker et al. BRITISH JOURNAL OF RADIOLOGY
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients
- (2012) Arnab Chakravarti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells
- (2012) Caroline Happold et al. JOURNAL OF NEUROCHEMISTRY
- The addition of Sunitinib to radiation delays tumor growth in a murine model of glioblastoma
- (2012) Randy D’Amico et al. NEUROLOGICAL RESEARCH
- Does Extent of Resection of a Glioblastoma Matter?
- (2012) Michael A. Vogelbaum NEUROSURGERY
- Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy
- (2012) Avadhut D. Joshi et al. PLoS One
- PDGF and PDGF receptors in glioma
- (2012) Inga Nazarenko et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
- (2011) M Miyamoto et al. BRITISH JOURNAL OF CANCER
- IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
- (2011) Qi SongTao et al. CANCER SCIENCE
- Antitumor Activity of NVP-BKM120--A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
- (2011) D. Koul et al. CLINICAL CANCER RESEARCH
- Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib--A Phase II Trial
- (2011) M. E. Hegi et al. MOLECULAR CANCER THERAPEUTICS
- A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
- (2011) J. J. Raizer et al. NEURO-ONCOLOGY
- Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer
- (2011) Matthew T. Burger et al. ACS Medicinal Chemistry Letters
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme
- (2010) John D. Hainsworth et al. CANCER
- Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma
- (2010) Ho-Shin Gwak et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
- (2010) Joon H. Uhm et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study
- (2010) W. K. A. Yung et al. NEURO-ONCOLOGY
- Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma
- (2010) D. Koul et al. NEURO-ONCOLOGY
- Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
- (2010) F. M. Iwamoto et al. NEURO-ONCOLOGY
- Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
- (2009) B. Neyns et al. ANNALS OF ONCOLOGY
- Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
- (2009) J. Felsberg et al. CLINICAL CANCER RESEARCH
- Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors
- (2009) Fabrizio Griffero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The EGFRvIII variant in glioblastoma multiforme
- (2009) Hui K. Gan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
- (2009) Gregor Dresemann et al. JOURNAL OF NEURO-ONCOLOGY
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
- (2009) James W Welsh et al. Radiation Oncology
- Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival?
- (2009) Faramarz- Allahdini et al. World Neurosurgery
- Prognostic significance of c-Met expression in glioblastomas
- (2008) Doo-Sik Kong et al. CANCER
- Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study
- (2008) Eric Raymond et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
- (2008) Michael D. Prados et al. JOURNAL OF CLINICAL ONCOLOGY
- p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation
- (2008) Hongwu Zheng et al. NATURE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now